Katakura  Industries  Co.,Ltd. Logo

Katakura Industries Co.,Ltd.

Diversified company in real estate, pharmaceuticals, machinery, and textiles.

3001 | T

Overview

Corporate Details

ISIN(s):
JP3211400001
LEI:
Country:
Japan
Address:
中央区明石町6番4号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Katakura Industries Co., Ltd. is a diversified company with operations spanning multiple sectors. The company's core business segments include Real Estate, Pharmaceuticals, Machinery, and Textiles. In real estate, its activities involve the management of commercial facilities, leasing of properties, and the development and utilization of company-owned land. The pharmaceutical division manufactures and sells medications, with a focus on treatments for cardiovascular illnesses such as angina pectoris and cardiac infarction. Additionally, the company engages in the manufacture and sale of mechanical equipment and maintains its legacy operations in the textile industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 04:45
Interim / Quarterly Report
確認書
Japanese 8.7 KB
2025-08-13 04:43
Interim / Quarterly Report
半期報告書-第117期(2025/01/01-2025/12/31)
Japanese 246.8 KB
2025-06-11 09:00
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.4 KB
2025-04-03 09:00
AGM Information
臨時報告書
Japanese 23.6 KB
2025-03-28 05:22
Governance Information
内部統制報告書-第116期(2024/01/01-2024/12/31)
Japanese 23.3 KB
2025-03-28 05:18
Registration Form
確認書
Japanese 8.7 KB
2025-03-28 05:16
Annual Report
有価証券報告書-第116期(2024/01/01-2024/12/31)
Japanese 1.3 MB
2024-09-11 09:00
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.4 KB
2024-08-09 08:40
Interim / Quarterly Report
確認書
Japanese 8.7 KB
2024-08-09 08:38
Interim / Quarterly Report
半期報告書-第116期(2024/01/01-2024/12/31)
Japanese 254.9 KB
2024-05-14 08:47
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-05-14 08:45
Quarterly Report
四半期報告書-第116期第1四半期(2024/01/01-2024/03/31)
Japanese 192.4 KB
2024-04-03 09:09
AGM Information
臨時報告書
Japanese 30.7 KB
2024-03-28 05:36
Governance Information
内部統制報告書-第115期(2023/01/01-2023/12/31)
Japanese 23.0 KB
2024-03-28 05:33
Registration Form
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all Katakura Industries Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Katakura Industries Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Katakura Industries Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Develops medical devices, diagnostics, nutritionals, and pharmaceuticals for global health.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900

Talk to a Data Expert

Have a question? We'll get back to you promptly.